With 70% In Favor, Could Nebraska’s Cannabis Program Unlock Underserved Markets? Local Expert Weighs In
Nebraska, one of the last strongholds of cannabis prohibition, is approaching a critical moment with medical cannabis initiatives set to appear on the November 2024 ballot. In an exclusive interview with Benzinga Cannabis, Paula Savchenko, Esq., founding partner of Cannacore Group and PS Law Group, discussed the main obstacles, how the proposed program addresses patient needs and the potential opportunities for investors in this emerging market.
Get Benzinga’s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. You can’t afford to miss out if you’re serious about the business.
Legal Challenges Leading Up To The 2024 Election
There are two separate initiatives in Nebraska related to medical cannabis. While one initiative focuses on the legalization of medical cannabis for patients, the other addresses the regulation of the medical cannabis industry. This strategy was employed to avoid violating the single-subject rule, which had caused issues during earlier attempts to get the initiative on the ballot.
The Nebraska Medical Cannabis initiatives are facing significant legal challenges. “The primary issues stem from questions about the validity of signatures and the violation of the single-subject rule,” Savchenko explained.
Led by former Senator John Kuehn and Smart Approaches to Marijuana (SAM), these challenges seek to remove the initiative from the ballot. While fraudulent signatures in Hall County have raised concerns, Savchenko noted, …